Principal Investigators
David GRABLI
Institution
APHP Paris
Contact information of lead PI
Country
France
Title of project or programme
Dénervation dopaminergique et polymorphisme de la COMT chez les patients parkinsoniens de novo. Plasma tau protein and biomarkers of amyloid precursor protein (APP) for the diagnosis and prognosis of Alzheimer's disease. Ancillary study under study BALTAZAR (Biomarker of AmyLoïd pepTide and AlZheimer's diseAse Risk).
Source of funding information
DGOS
Total sum awarded (Euro)
197,000
Start date of award
xx/xx/2013
Total duration of award in years
3
Keywords
Research Abstract
Further information available at:
Types: Investments < €500k
Member States: France
Diseases: N/A
Years: 2016
Database Categories: N/A
Database Tags: N/A